Sativex
Sativex® is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain and neuropathic pain of various origins...
Now approved in the UK, Spain, Germany, Denmark, the Czech Republic, Sweden, New Zealand and Canada. See map below for future growth
Please note that we cannot provide advice on the suitability of Sativex for individual patients.
Patients wishing to know more about Sativex should discuss with their doctor the most suitable treatment for them.
